Deukwoo Kwon

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Professor

UAMS

Also affiliated: Fox Chase Cancer Center (2016); National Institutes of Health (2008–2016); Mount Sinai Hospital (2025); The University of Texas MD Anderson Cancer Center (2012); University of Miami (2012–2025); The University of Texas at El Paso (2007); Cancer Institute (WIA) (2009–2014); Asan Medical Center (2014); Jackson Memorial Hospital (2016–2019); Institute for Research in Immunology and Cancer (2014); University of Miami Health System (2018–2021); Office of Multidisciplinary Activities (2023); National Center for Biotechnology Information (2014); National Cancer Institute (2011); Stanford Medicine (2016); National Cancer Institute (2007–2016); Cancer Genetics (United States) (2009); Sylvester Comprehensive Cancer Center (2012–2025); The University of Texas Health Science Center (2023–2025); Miami VA Healthcare System (2018); Department of Health and Human Services (2009–2016); Division of Cancer Epidemiology and Genetics (2007–2014); Pusan National University (2016); Université de Montréal (2014); University of Pennsylvania (2007); Myongji University (2014); Texas A&M University (2007); The University of Texas Health Science Center at Houston (2022–2025); Stanford University (2016); Icahn School of Medicine at Mount Sinai (2022–2026)

Faculty Researcher

40 h-index 352 pubs 5,071 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Deukwoo Kwon's research portfolio includes investigations into various aspects of medical science, with a particular focus on cancer and hematologic malignancies. His work has explored the mechanisms underlying treatment response and resistance, such as the role of neutrophil-mediated signaling in pancreatic cancer chemotherapy response and the potentiation of all-trans retinoic acid treatment by LSD1 inhibition in myeloid malignancies. Kwon has also studied the incidence, clinical presentation, risk factors, and outcomes of de novo late acute graft-versus-host disease (GVHD).

His recent publications also indicate an interest in diagnostic accuracy and medical imaging techniques. This includes an assessment of dermoscopic structures and patterns for melanoma detection and an evaluation of the repeatability and correlation of radiomic features from CBCT and CT imaging for prostate cancer. Additionally, Kwon has contributed to the development of computational tools for meta-analysis, such as the R shiny application ABCMETAapp for simulation-based estimation of mean and standard deviation.

With a substantial publication record of 353 papers and an h-index of 40, Kwon's work has been cited over 5,000 times, reflecting a broad impact in his fields of study. His research spans multiple areas within health sciences, encompassing disease mechanisms, treatment efficacy, and diagnostic methodologies.

Metrics

h-index: 40
Publications: 352
Citations: 5,071

Selected Publications

Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomes (2025)

The Oncologist 1 citation DOI OpenAlex
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effects (2025)

Molecular Therapy 2 citations DOI OpenAlex
Daratumumab with Dose-Adjusted EPOCH Is Feasible in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105 (2024)

Blood 8 citations DOI OpenAlex
Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer (2024)

Cancer Research 4 citations DOI OpenAlex
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD (2024)

Blood Advances 15 citations DOI OpenAlex
A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability (2024)

JMIR Cancer 1 citation DOI OpenAlex
Power calculation for detecting interaction effect in cross-sectional stepped-wedge cluster randomized trials: an important tool for disparity research (2024)

BMC Medical Research Methodology 1 citation DOI OpenAlex
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers (2024)

American Journal of Clinical Pathology 3 citations DOI OpenAlex
A Day 14 Endpoint for Acute GVHD Clinical Trials (2024)

Transplantation and Cellular Therapy 11 citations DOI OpenAlex
A Multi-institutional Analysis of Factors Influencing the Rate of Positive MRI Biopsy Among Women with Early-Stage Breast Cancer (2024)

Annals of Surgical Oncology 5 citations DOI OpenAlex
Frequentist model averaging for analysis of dose–response in epidemiologic studies with complex exposure uncertainty (2023)

PLoS ONE 5 citations DOI OpenAlex
Predicting response to immunotherapy in non-small cell lung cancer- from bench to bedside (2023)

Frontiers in Oncology 8 citations DOI OpenAlex
Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI (2023)

Cancers 5 citations DOI OpenAlex
Medication Reconciliation during Transitions of Care Across Institutions: A Quantitative Analysis of Challenges and Opportunities (2023)

Applied Clinical Informatics 4 citations DOI OpenAlex
Impact of Neighborhood Disadvantage on Tumor Biology and Breast Cancer Survival (2023)

Annals of Surgery 12 citations DOI OpenAlex